Works matching IS 03407004 AND DT 2019 AND VI 68 AND IP 8


Results: 15
    1
    2
    3
    4
    5
    6

    Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 8, p. 1351, doi. 10.1007/s00262-019-02367-z
    By:
    • Bonaventura, Aldo;
    • Grossi, Francesco;
    • Carbone, Federico;
    • Vecchié, Alessandra;
    • Minetti, Silvia;
    • Bardi, Nicholas;
    • Elia, Edoardo;
    • Ansaldo, Anna Maria;
    • Ferrara, Daniele;
    • Rijavec, Erika;
    • Dal Bello, Maria Giovanna;
    • Rossi, Giovanni;
    • Biello, Federica;
    • Tagliamento, Marco;
    • Alama, Angela;
    • Coco, Simona;
    • Spallarossa, Paolo;
    • Dallegri, Franco;
    • Genova, Carlo;
    • Montecucco, Fabrizio
    Publication type:
    Article
    7

    Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 8, p. 1341, doi. 10.1007/s00262-019-02366-0
    By:
    • Urakawa, Shinya;
    • Yamasaki, Makoto;
    • Goto, Kumiko;
    • Haruna, Miya;
    • Hirata, Michinari;
    • Morimoto-Okazawa, Akiko;
    • Kawashima, Atsunari;
    • Iwahori, Kota;
    • Makino, Tomoki;
    • Kurokawa, Yukinori;
    • Yamada, Tomomi;
    • Mori, Masaki;
    • Doki, Yuichiro;
    • Wada, Hisashi
    Publication type:
    Article
    8
    9
    10
    11

    Reduced CTL motility and activity in avascular tumor areas.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 8, p. 1287, doi. 10.1007/s00262-019-02361-5
    By:
    • Manaster, Yoav;
    • Shipony, Zohar;
    • Hutzler, Anat;
    • Kolesnikov, Masha;
    • Avivi, Camila;
    • Shalmon, Bruria;
    • Barshack, Iris;
    • Besser, Michal J.;
    • Feferman, Tali;
    • Shakhar, Guy
    Publication type:
    Article
    12
    13

    Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 8, p. 1273, doi. 10.1007/s00262-019-02357-1
    By:
    • Ishida, Eiichi;
    • Lee, Jina;
    • Campbell, Jean S.;
    • Chakravarty, Patrick D.;
    • Katori, Yukio;
    • Ogawa, Takenori;
    • Johnson, Lauren;
    • Mukhopadhyay, Anandaroop;
    • Faquin, William C.;
    • Lin, Derrick T.;
    • Wirth, Lori J.;
    • Pierce, Robert H.;
    • Pai, Sara I.
    Publication type:
    Article
    14
    15